- TRADE NAMES: Azol; Bonzol; Cyclomen; D-Zol; Danocrine; Danol; Ladogal; Winobanin; Zoldan-A
- INDICATIONS: Endometriosis, fibrocystic breast disease
- CLASS: Pituitary hormone inhibitor
- HALF-LIFE: ~4.5 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acenocoumarol, Acitretin, Atorvastatin, Cyclosporine, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Oral Contraceptives, Paricalcitol, Simvastatin, Tacrolimus, Warfarin
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
